Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-12-24
1991-10-29
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424445, 424447, 514 10, A61K 3700, A61K 3714
Patent
active
050616897
ABSTRACT:
Bacitracin zinc is effective to promote regenerative healing when topically applied to wounds in concentrations from about 5% to 8%. The bacitracin zinc can be applied in a hydrophilic or hydrophobic carrier, and is advantageously impregnated in an absorbent pad.
REFERENCES:
patent: 2809149 (1957-10-01), Cusumano
patent: 3419006 (1968-12-01), King
Physicians' Desk Reference, 26th ed., 1972, p. 690 ("Neo-Polycin").
Physicians' Desk Reference, pp. 303, 764, 765, Edition 35, 1981, Charles E. Baker, Jr., Publisher.
The Pharmacological Basis of Therapeutics, pp. 1293, 1294, Edition 4, 1970, Edited by Louis S. Goodman, M.A., M.D., D. Sc. (Hon.) and Alfred Gilman, Ph.D.
Bioderm, Inc.
Schenkman Leonard
LandOfFree
Zinc bacitracin containing wound dressing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Zinc bacitracin containing wound dressing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Zinc bacitracin containing wound dressing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1400649